1. Gibb, W. R. & Lees, A. J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. Journal of neurology, neurosurgery, and psychiatry 51, 745–752 (1988).
2. Fox, S. H. et al. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson’s disease. Movement disorders: official journal of the Movement Disorder Society 26(Suppl 3), 41 (2011).
3. Braak, H. et al. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). Journal of neurology 249(Suppl 3), 3–5 (2002).
4. Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839–840 (1997).
5. Bendor, J. T., Logan, T. P. & Edwards, R. H. The function of α-synuclein. Neuron 79, 1044–1066 (2013).